A study on rats suggests that microdosing psilocybin could reduce stress-induced anhedonia and compulsive behaviors without causing anxiety or schizophrenia-like symptoms. This research offers insights into psilocybin's potential as a therapy for mental health disorders, though further human studies are...
Researchers at the University of Chicago found that low doses of LSD may have antidepressant effects in individuals with mild to moderate depression. This groundbreaking study opens new possibilities for alternative mental health treatments.
Adults with ADHD who practiced microdosing psychedelics reported increased mindfulness after four weeks, according to a study in Frontiers in Psychiatry. The research highlights the need for controlled studies to validate these findings
In recent years, the trend of microdosing psychedelics has gained popularity, with enthusiasts touting a wide range of potential benefits, from enhanced creativity to improved mood and focus. However, a recent scientific review published in the Journal of Psychopharmacology has...
The practice of "microdosing" appears to result in a decrease in emotional diversity, according to new research published in the Journal of Psychedelic Studies.
A single, low dose of lysergic acid diethylamide (LSD) can increase reward-related brain activity, according to new research published in Neuropsychopharmacology. The study indicates that the psychedelic drug alters neuropsychological processes that tend to be blunted in patients with depression.
Anecdotal evidence suggests that microdosing with psilocybin mushrooms offers mental health benefits. But a recent experimental study suggests that these purported benefits may be driven by users’ expectations. Findings from the placebo-controlled experiment were published in the journal Translational Psychiatry.
Psilocybin, the active compound in “magic mushrooms,” has been shown to be a promising treatment for various mental health issues. New research published in Scientific Reports found that people who microdose psychedelics displayed greater improvements in mental health and mood...
A new randomized controlled study of LSD microdosing has failed to find evidence that the psychedelic practice results in improvements to mood or cognition.
Zebrafish might seem an odd choice in studying human health, but they share 70 per cent of their genes with us and are a popular nonhuman organism used by scientists to study biological processes. They are also incredibly social, making...
Consuming small doses of psilocybin at regular intervals -- a process known as microdosing -- does not appear to improve symptoms of depression or anxiety, according to new research published in the Journal of Psychopharmacology. The placebo-controlled study casts doubt...
Low doses of psilocybin and ketamine can heighten food-related motivation and improve attention in poorly-performing male rats, according to new research published in Frontiers in Pharmacology. The new findings shed light on some of the potential benefits of microdosing, which...
Lysergic acid diethylamide, or LSD, is a drug which produces a variety of cognitive, perceptual and behavioral changes in users. One of these is distortions in interval timing: one’s perception of (relatively) short intervals and, specifically, the ability to reliably...
Microdosing has become something of a wellness trend in recent years, gathering traction in Australia and overseas. The practice involves taking a low dose of a psychedelic drug to enhance performance, or reduce stress and anxiety. While the anecdotal accounts...
A study published in Psychopharmacology suggests that people may turn to microdosing with psychedelics in an attempt to improve their mental health. According to most self-reports, these attempts may be effective. Interest in psychedelic drugs as a potential treatment option...